RONALD C. RENAUD joined the Bear, Stearns Healthcare/Biotechnology team
in May 2001 as an Associate Director. Previously, he was a Senior
Biotechnology Analyst at JP Morgan Chase covering companies in the life
science technology sector. Prior to joining JP Morgan Chase in May 2000,
he was an Associate Analyst on the Healthcare/Biotechnology team at
Bear, Stearns. From 1994 to 1999, Mr. Renaud worked at Amgen in clinical
research and development as well as finance. From 1990 to 1994, Ron
worked at the Dana-Farber Cancer Institute with roles in both clinical
and basic research. He holds a BA from Saint Anselm College and an MBA
from the Marshall School of Business at the University of Southern
California.
Large Cap Biotechnology & Life Sciences: Ronald Renaud - Bear, Stearns & Co
September 13, 2002
Large Cap Biotechnology Stocks: Ronald Renaud - Bear, Stearns & Co
September 14, 2001